Domino's Pizza, Inc. vs Medtronic PLC — how do they compare? Domino's Pizza, Inc. trades at $309.8 (market cap $10.21B), while Medtronic PLC trades at $89.09 (market cap $112.24B). The key difference: Medtronic PLC is far larger — about 11× Domino's Pizza, Inc.'s market cap, and Medtronic PLC pays the higher dividend (3.28%). Which is the better fit depends on your goals — on Pluang, investors hold Domino's Pizza, Inc. for 106 Days and Medtronic PLC for 63 Days on average.
| DPZ | MDT | |
|---|---|---|
Market Cap | $10.21B | $112.24B |
Volume | 916,737 | 105,663,236 |
Sector | Consumer Cyclical | Health |
52-Week High | $438.42 | $105.35 |
52-Week Low | $282.89 | $73.75 |
Typical Hold Time | 106 Days | 63 Days |
Enterprise Value | $15.17B | $131.58B |
Dividend Yield | 2.58% | 3.28% |
Signals from Pluang's Aura AI — not financial advice
Domino's Pizza (DPZ) trades at $309.44, up 2.09% today, with a bullish technical signal despite recent earnings misses. The company maintains strong fundamentals with $4.94B revenue, 11.86% net margin, and positive cash flow trends. Recent news highlights dividend stability, store closures, and upcoming Q3 earnings on October 13, 2026.
DPZ presents a mixed outlook with analyst consensus at Buy (50%) and $373 price target offering 21% upside, but faces risks from high debt load and recent earnings underperformance. The stock's valuation at 17.5 P/E appears reasonable if growth resumes post-Q3 results.
Medtronic (MDT) trades at $85.51, down 1.81% on the day, with the stock showing bearish technical signals despite strong fundamental performance. The company has beaten earnings expectations for three consecutive quarters, maintains a healthy 13.93% net income margin, and offers a solid 3.2% dividend yield with 49 consecutive years of dividend growth. Recent positive developments include FDA clearances for new medical technologies and raised full-year guidance.
MDT presents a compelling value opportunity with analyst consensus pointing to 14% upside to the $97.80 price target. The stock's current valuation multiples (P/E 21.61, P/S 3.01) appear reasonable given the company's stable revenue growth and strong cash flow generation. Key risks include increasing debt levels and competitive pressures in the medical device sector, but the company's dividend aristocrat status and improving operational performance support a positive long-term outlook.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →